share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4:持股變動聲明-高管 Amman Bradford K.
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心訊息
Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.
Bradford K. Amman, the Chief Financial Officer of Vivos Therapeutics, Inc. (VVOS), has engaged in a transaction involving the company's common stock on June 20, 2024. Following the transaction, Amman directly holds a total of 80 shares of Vivos Therapeutics. The nature of the shares is direct, indicating personal ownership. The transaction details, including the number of shares transacted and the price, have not been disclosed. This financial activity is part of the regular disclosure of stock transactions by company insiders, which can be an indicator of the company's financial health and management's confidence in the business.
Vivos Therapeutics(臨時代碼vivos therapeutics)的首席財務官Bradford K. Amman於2024年6月20日參與了一項涉及該公司普通股的交易。該交易後,Amman直接持有Vivos Therapeutics的80股股票。股份的性質是直接的,表明這是個人所有權。交易細節,包括交易的股票數量和價格,尚未披露。這種財務活動是公司內部人士股票交易的定期披露的一部分,這可能是公司財務狀況和管理層對業務的信懇智能的指標。
Vivos Therapeutics(臨時代碼vivos therapeutics)的首席財務官Bradford K. Amman於2024年6月20日參與了一項涉及該公司普通股的交易。該交易後,Amman直接持有Vivos Therapeutics的80股股票。股份的性質是直接的,表明這是個人所有權。交易細節,包括交易的股票數量和價格,尚未披露。這種財務活動是公司內部人士股票交易的定期披露的一部分,這可能是公司財務狀況和管理層對業務的信懇智能的指標。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息